From Yahoo Finance: 2025-04-22 13:40:00

The telehealth market in the US was valued at $42.54 billion in 2024, with an expected growth rate of 23.8% between 2025 and 2030. Factors driving this growth include rising demand for remote healthcare, connected home services, high internet usage, and global smartphone adoption.

Telehealth offers a significant opportunity in healthcare as it can virtualize around $250 billion of current US healthcare spending. This includes medical training, check-ins for chronic diseases, psychiatric care, and more, accessible through preferred devices.

CVS Health Corporation (NYSE: CVS) ranks among the best telehealth stocks to buy, offering connected care solutions across healthcare benefits, services, pharmacy, and consumer wellness. With a diverse business portfolio and recent revenue growth, CVS shows promise despite management changes.

Recently, Morgan Stanley raised CVS Health Corporation’s price target to $80, citing optimism around the company’s future performance. Patient Capital Management sees potential for improved margins in 2025, supported by management changes and a strong asset base in healthcare benefits, pharmacy benefits, and in-home care services.

Ranked 2nd on the list of best telehealth stocks, CVS presents an investment opportunity, but AI stocks may offer higher returns in a shorter time frame. An AI stock showing promise with significant upside potential is highlighted for investors seeking alternative opportunities.

Read more: Is CVS Health Corporation (CVS) the Best Telehealth Stock to Buy Now?